These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 387044)

  • 1. [On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
    Hennings G
    Arzneimittelforschung; 1979; 29(5):720-4. PubMed ID: 387044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of (+)cyanidanol-3 in acute liver injury induced by galactosamine or carbon tetrachloride in the rat.
    Perrissoud D; Weibel I
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):285-91. PubMed ID: 7402370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of (+)-cyanidanol-3 on toxic fatty infiltration of liver parenchyma (author's transl)].
    Meiss R; Rassat J; Themann H
    Arzneimittelforschung; 1982; 32(2):139-40. PubMed ID: 6802144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of (+)-cyanidanol-3 on the changes in liver glutathione content and lipoperoxidation induced by acute ethanol administration in the rat.
    Videla LA; Fernández V; Valenzuela A; Ugarte G
    Pharmacology; 1981; 22(6):343-8. PubMed ID: 7267700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of (+)cyanidanol-3 on the inhibition of protein synthesis and secretion after galactosamine injection.
    Reutter W; Hassels B
    Biochem Pharmacol; 1980 Aug; 29(16):2258-9. PubMed ID: 7426031
    [No Abstract]   [Full Text] [Related]  

  • 7. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W; Leube G
    Med Klin; 1978 Oct; 73(41):1432-6. PubMed ID: 703670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies on the effect of hepatoprotective compounds.
    Lapis K; Jeney A; Divald A; Vajta G; Zalatnai A; Schaff Z
    Tokai J Exp Clin Med; 1986; 11 Suppl():135-45. PubMed ID: 3330627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the antioxidant (+)-cyanidanol-3 on H2O2 formation and lipid peroxidation in liver microsomes.
    Ritter J; Kahl R; Hildebrandt AG
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):48-58. PubMed ID: 3983470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bilirubin transport across the liver by the flavonoids (+)-cyanidanol-3 and palmitoyl-catechin.
    Ricci GL; Baldassarre V; Longo G; Zanninelli G
    Arzneimittelforschung; 1986 Apr; 36(4):691-4. PubMed ID: 3087370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
    Altorjay I; Dalmi L; Sári B
    Acta Physiol Hung; 1984; 64(3-4):471-4. PubMed ID: 6532130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental models for the study of hepatoprotection.
    Fehér J; Pollák Z; Sréter L; Toncsev H; Cornides A; Gógl A; Vereckei A
    Acta Physiol Hung; 1984; 64(3-4):401-7. PubMed ID: 6532127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of (+)-cyanidanol-3 on rat brain lipid peroxidation.
    Fehér J; Blázovics A; Cornides A; Vereckei A
    Br J Exp Pathol; 1985 Apr; 66(2):161-4. PubMed ID: 3986129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Hydroxyoestradiol and (+)-cyanidanol-3 prevent lipid peroxidation of isolated rat hepatocytes.
    Kappus H; Köster-Albrecht D; Remmer H
    Arch Toxicol Suppl; 1979; (2):321-6. PubMed ID: 288339
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J; Toncsev H; Sréter L; Cornides A; Kiss A
    Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of silymarin and (+)-cyanidanol-3 on the HCB-induced porphyria in rats (author's transl)].
    Thier W; Bolsen K; Goerz G
    Z Gastroenterol; 1982 Jan; 20(1):40-6. PubMed ID: 7064495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
    Perrissoud D; Maignan MF; Dumont JM
    Liver; 1985 Apr; 5(2):55-63. PubMed ID: 3999934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
    Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyanidanol: will a hepatotrophic drug from Europe go west?
    Hepatology; 1983; 3(1):121-3. PubMed ID: 6822375
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic activity of (+)-cyanidanol-3 in animal experiments].
    Scevola D; Bonizzoni D; Concia E; Azzini M; Magliulo E
    Clin Ter; 1980 Oct; 95(1):43-58. PubMed ID: 7471649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.